Dublin, United States
Monitored Therapeutics, Inc. is a Remote Patient Monitoring Company specializing in COPD, Asthma, Lung Transplant, and Cystic Fibrosis. It offers four proprietary products - GoSpiro® Home Spirometer, GoHome™ Patient Health Monitor, GoClinic, GoECG, and the MTI CarePortal™. The company's GoSpiro® is an FDA 510(k) cleared spirometer capable of providing lab-quality results in the home, ensuring accurate and reliable monitoring of respiratory conditions.
Founded in 2011 and headquartered in the United States, MTI focuses on Respiratory Disease Management and aims to extend Access to Care to patients and healthcare providers through a standardized platform. By leveraging technology, MTI increases Patient Engagement, Drug Adherence, and Quality of Life, while simultaneously decreasing overall healthcare costs by enabling patients to receive care in their homes and avoid unnecessary hospital visits.
The company recently secured a $4.27M Venture Round investment on 27 July 2021. This investment will likely accelerate the development and market penetration of MTI's innovative solutions, positioning the company as a key player in the Healthcare industry and potentially opening up opportunities for expansion and further partnerships. With its focus on improving patient outcomes and reducing healthcare costs, MTI presents an attractive opportunity for venture capital firms seeking to invest in innovative healthcare solutions.
